Compare Fortinet Inc (FTNT) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fortinet Inc vs IDEXX Laboratories, Inc. — how do they compare? Fortinet Inc trades at $166 (market cap $120.53B), while IDEXX Laboratories, Inc. trades at $576.42 (market cap $43.94B). The key difference: Fortinet Inc is far larger — about 2.7× IDEXX Laboratories, Inc.'s market cap, and Fortinet Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| FTNT | IDXX | |
|---|---|---|
Market Cap | $120.53B | $43.94B |
Sector | Technology | Health |
52-Week High | $166.83 | $766.68 |
52-Week Low | $74.39 | $514.61 |
Enterprise Value | $117.73B | $44.84B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fortinet (FTNT) trades at $161.46, down 3.22% today, but maintains a bullish technical signal with strong moving averages and support near $162. The company reported consistent earnings beats, with Q1 2026 EPS of $0.82 surpassing the $0.619 estimate, and demonstrates robust fundamentals including 80.3% gross margins and 27.49% net income margin. Recent news highlights AI-driven cybersecurity demand as a growth catalyst, with Fortinet expanding its FortiEndpoint platform for AI security (GlobeNewsWire, July 14, 2026).
Outlook is positive due to AI cybersecurity tailwinds and earnings momentum, but high valuation ratios (P/E of 63.76, P/S of 17.5) pose risks if growth slows. Analyst consensus is mixed with 42.65% buy ratings, though the $123.16 price target suggests caution relative to current levels. Key risks include competitive pressures and reliance on enterprise IT spending cycles.
IDXX trades at $572.38, up 5.86% over 24 hours, with a neutral technical signal and strong fundamentals. The company reported Q1 2026 EPS of $3.47, beating estimates, and maintains robust profitability with a 24.63% net margin. Revenue growth accelerated to $4.3 billion in 2025, supported by innovation in veterinary diagnostics and AI integration. Cash flow from operations remains healthy at $1.18 billion, though net cash flow was negative $108 million due to financing activities.
Outlook is positive given consistent earnings beats and analyst consensus leaning buy (59% of ratings). Key risks include high valuation multiples (P/E 40.99) and competitive pressures in medical devices. The stock's proximity to its 52-week high suggests momentum but warrants caution on pullbacks. Institutional sentiment is bolstered by product expansions like taeniid tapeworm detection and SDMA integration for kidney disease screening.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fortinet Inc
Fortinet is a cybersecurity vendor that sells products, support, and services to small and midsize businesses, enterprises, and government entities. Its products include unified threat management appliances, firewalls, network security, and its security platform, Security Fabric. Services revenue is primarily from FortiGuard security subscriptions and FortiCare technical support. At the end of 2021, products were 38% of revenue and services were 62% of sales. The California-based company sells products worldwide.
Read more on FTNT →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
